Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00510367 · ClinicalTrials.gov registry record · Early Phase 1
Primary Breast Cancer Occurring Concomitant With Pregnancy
A Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 61
- Enrollment target
NCT00510367: Completed Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT00510367 is a Early Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 61 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (15% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00510367, a Early Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 61 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn the results of multimodality (chemotherapy, surgery and radiation therapy) treatment of primary breast cancer that occurs at the same time as pregnancy. Researchers want to evaluate the outcome of labor and delivery as well as evaluate the long-term health outcomes of children exposed to chemotherapy while in their mother's womb.
Primary Outcome
Ultrasound obtained after four cycles of neoadjuvant chemotherapy to assess response.
Interventions
- DRUG Cyclophosphamide
- DRUG Doxorubicin
- DRUG 5-Fluorouracil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2001-08-07 |
| Est. Completion | 2020-07-08 |
| Phase | Early Phase 1 |
What the finished NCT00510367 record still lists
NCT00510367 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (15% higher).
The record links to 0 conditions, and to 3 interventions - of which Cyclophosphamide is the first listed.
NCT00510367 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00510367 about?
NCT00510367 is a clinical study titled "Primary Breast Cancer Occurring Concomitant With Pregnancy". The goal of this clinical research study is to learn the results of multimodality (chemotherapy, surgery and radiation therapy) treatment of primary breast cancer that occurs at the same time as pregnancy. Researchers want to evaluate the outcome of labor and delivery as well as evaluate the long-te...
What is the current status of trial NCT00510367?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 61 participants. The study started on 2001-08-07. Estimated completion is 2020-07-08.
What interventions are being tested in trial NCT00510367?
The interventions under investigation include: Cyclophosphamide (DRUG), Doxorubicin (DRUG), 5-Fluorouracil (DRUG).
Who is sponsoring clinical trial NCT00510367?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00510367's enrollment target sits among peer trials
61 397th of 2000 higher than 1,598 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI